FORM DEF 14A

Company

Emmaus Life Sciences, Inc.

Filed

October 31, 2022

Period of Report

December 8, 2022

Accession Number

0001140361-22-039001

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →